Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

(OP: POLBF )

0.1180 UNCHANGED
Last Price Updated: 3:19 PM EST, Nov 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.1180
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.1180
Today's Range 0.1180 - 0.1180
52wk Range 0.1070 - 0.2269
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Poolbeg Pharma PLC Announces Voluntary Delisting from OTCQB Market
Via ACCESSWIRE
Poolbeg Pharma PLC Announces Change of Registered Address
Via ACCESSWIRE

Performance

YTD
+10.28%
+10.28%
1 Month
N/A
N/A
3 Month
-21.85%
-21.85%
6 Month
-32.57%
-32.57%
1 Year
+10.28%
+10.28%

More News

Read More
Poolbeg Pharma PLC Announces Annual Report & AGM Notice
Via ACCESSWIRE
Poolbeg Pharma's POLB 001 immuno-modulator II receives fully-granted patent from US Patent Office
Via News Direct
Topics Intellectual Property
Exposures Intellectual Property
Poolbeg Pharma's POLB 001 immuno-modulator II receives fully-granted patent from US Patent Office
Via TheNewswire.com
Topics Intellectual Property
Exposures Intellectual Property
Poolbeg Pharma PLC Announces Significant POLB 001 Patent Granted in USA
Via ACCESSWIRE
Poolbeg Pharma PLC Announces Results for the Year Ended 31 December 2023
Via ACCESSWIRE
Poolbeg Pharma PLC Announces Option Agreement to Acquire Orphan Drug Candidate
Via ACCESSWIRE
Poolbeg Pharma PLC Announces TR-1: Notification of Major Holdings
Via ACCESSWIRE
Poolbeg Pharma PLC Announces Appointment of Joint Broker
Via ACCESSWIRE
Poolbeg Pharma PLC Announces POLB 001 US Patent Update
Via ACCESSWIRE
Poolbeg Pharma PLC Announces Director Share Purchase
Via ACCESSWIRE
Poolbeg Pharma PLC Announces POLB 001 Data Presented at ASH
Via ACCESSWIRE
Poolbeg Pharma PLC Announces Directorate Change
Via ACCESSWIRE
Poolbeg Pharma PLC Announces Immunomodulator II Patent Granted in Japan
Via ACCESSWIRE
Poolbeg Pharma PLC Announces POLB 001 LPS Trial Data to be Presented at IUIS
Via ACCESSWIRE
Former Amryt Pharma Leadership Team join Poolbeg
Via ACCESSWIRE
Poolbeg Pharma PLC Announces POLB 001 Data to be Presented at American Society of Hematology Annual Meeting
Via ACCESSWIRE
Poolbeg Pharma PLC Announces Board Role Change and Launch of EIP
Via ACCESSWIRE
Poolbeg Pharma PLC Announces Market Opportunity for POLB 001 for CRS
Via ACCESSWIRE
Poolbeg Pharma PLC Announces Further Data Shows POLB001 Potential in Cancer CRS
Via ACCESSWIRE
Poolbeg Pharma PLC Announces RSV AI Drug Candidate Analysis Update
Via ACCESSWIRE
Poolbeg Pharma PLC Announces POLB 001 Oncology Programme Update Meeting
Via ACCESSWIRE
Poolbeg Pharma unveils new collaboration agreement
Via News Direct
Poolbeg Pharma unveils new collaboration agreement
Via TheNewswire.com
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.